7th Annual Gene Therapy Immunogenicity

The 7th Annual Gene Therapy Immunogenicity addresses innovative strategies to manage immunogenicity challenges in gene therapy, focusing on overcoming immune hurdles, optimizing safety, and enhancing clinical success.

Key Topics

• Strategic insights into repeat dosing and immune management
• Maximizing trial success by standardizing assays and fostering collaboration
• Overcoming pre-existing immunity to AAV
• Enhancing translational success by addressing immunogenicity risks
• Overcoming immune hurdles by clearing antibodies and optimizing capsids
• Comparing differing administration routes for gene therapies

Who should Attend

• Gene therapy researchers and developers
• Clinical scientists working on immunogenicity management
• Regulatory professionals and policymakers
• Biotechnology and pharmaceutical company representatives
• Academics and research institutions specializing in gene therapy
• Immunologists and medical professionals involved in genetic treatments